Ardent Health, Inc. reported $6.41B of revenue over the trailing twelve months, +3.3% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.41B (to Q2 2026). Net income: $78M, trailing twelve months to Q2 2026. Operating margin: 3.2%, trailing twelve months to Q2 2026. EPS: $0.55, trailing twelve months to Q2 2026.

ARDTArdent Health, Inc.

Healthcare

$11.32-12% 1Y

$11.32

$7.8352 weeks$15.21

ARDT as reported

Ardent Health, Inc. reported $6.41B of revenue over the trailing twelve months, +3.3% on the year before. 9 reported series are charted on this page, each one as filed.

$6.41B

Revenue, trailing twelve months · to Q2 2026 · +3.3% against the twelve months before

Net income: $78M
Net income · −69% year on year · trailing twelve months to Q2 2026
Operating margin: 3.2%
Operating margin · trailing twelve months to Q2 2026
EPS: $0.55
EPS · −70% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ARDT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.41B	+3.3%	Q2 2026
Net income	$78M	−69%	Q2 2026
EPS	$0.55	−70%	Q2 2026
Operating margin	3.2%	n/a	Q2 2026
Net margin	1.2%	n/a	Q2 2026
ROE	11%	n/a	Q2 2026
ROA	2.6%	n/a	Q2 2026
ROIC	13%	n/a	Q2 2026
P/E	20.6	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.